Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Charles River Labs noted a slowdown in the worldwide CRO...
ChinaBio® Accelerator will hold the ChinaBio®...
An AIDS vaccine, developed by China scientists, produced...
China CRO Tigermed Consulting...
NovaMed Pharma paid $5 million for the China...
Looking forward, China is expected to release its...
We concluded our series on the “State of China Life...
WuXi PharmaTech (药明康德) reported a 5%...
Bayer HealthCare China discussed the company’s...
Xian-Janssen launched Dacogen, a myelodysplastic syndrome...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
